Spiro-bicyclo[2.2.2]octane derivatives as paclitaxel mimetics. Synthesis and toxicity evaluation in breast cancer cell lines.
(2013) In Organic and Biomolecular Chemistry 11(41). p.7134-7144- Abstract
 - Paclitaxel is one of the most important anti-cancer agents introduced during the last 20 years. However, the use of paclitaxel is limited by undesirable side effects as well as the development of drug resistance. Here, we report a synthetic strategy towards spiro-bicyclo[2.2.2]octane derivatives, which includes double Michael addition and ring-closing metathesis as key synthetic steps. This strategy was used to synthesize a series of spiro-bicyclic compounds designed to be paclitaxel mimetics, which were evaluated in human breast-derived cell lines. One of these paclitaxel mimetics showed toxicity, although at higher concentrations than paclitaxel itself. In addition, two other spiro-bicyclic compounds, lacking the paclitaxel side chain,... (More)
 - Paclitaxel is one of the most important anti-cancer agents introduced during the last 20 years. However, the use of paclitaxel is limited by undesirable side effects as well as the development of drug resistance. Here, we report a synthetic strategy towards spiro-bicyclo[2.2.2]octane derivatives, which includes double Michael addition and ring-closing metathesis as key synthetic steps. This strategy was used to synthesize a series of spiro-bicyclic compounds designed to be paclitaxel mimetics, which were evaluated in human breast-derived cell lines. One of these paclitaxel mimetics showed toxicity, although at higher concentrations than paclitaxel itself. In addition, two other spiro-bicyclic compounds, lacking the paclitaxel side chain, showed toxicity. (Less)
 
    Please use this url to cite or link to this publication:
    https://lup.lub.lu.se/record/4065510
- author
 - 						Manner, Sophie
				LU
	; 						Oltner, Viveca
	; 						Oredsson, Stina
				LU
	; 						Ellervik, Ulf
				LU
				
	 and 						Frejd, Torbjörn
				LU
	 - organization
 - publishing date
 - 2013
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - in
 - Organic and Biomolecular Chemistry
 - volume
 - 11
 - issue
 - 41
 - pages
 - 7134 - 7144
 - publisher
 - Royal Society of Chemistry
 - external identifiers
 - 
                
- wos:000326010300015
 - pmid:24057031
 - scopus:84885087746
 
 - ISSN
 - 1477-0539
 - DOI
 - 10.1039/c3ob41417e
 - language
 - English
 - LU publication?
 - yes
 - id
 - 15e2d3f7-0371-43b8-ad1c-78b531e99a7d (old id 4065510)
 - date added to LUP
 - 2016-04-01 11:09:08
 - date last changed
 - 2025-10-14 10:45:22
 
@article{15e2d3f7-0371-43b8-ad1c-78b531e99a7d,
  abstract     = {{Paclitaxel is one of the most important anti-cancer agents introduced during the last 20 years. However, the use of paclitaxel is limited by undesirable side effects as well as the development of drug resistance. Here, we report a synthetic strategy towards spiro-bicyclo[2.2.2]octane derivatives, which includes double Michael addition and ring-closing metathesis as key synthetic steps. This strategy was used to synthesize a series of spiro-bicyclic compounds designed to be paclitaxel mimetics, which were evaluated in human breast-derived cell lines. One of these paclitaxel mimetics showed toxicity, although at higher concentrations than paclitaxel itself. In addition, two other spiro-bicyclic compounds, lacking the paclitaxel side chain, showed toxicity.}},
  author       = {{Manner, Sophie and Oltner, Viveca and Oredsson, Stina and Ellervik, Ulf and Frejd, Torbjörn}},
  issn         = {{1477-0539}},
  language     = {{eng}},
  number       = {{41}},
  pages        = {{7134--7144}},
  publisher    = {{Royal Society of Chemistry}},
  series       = {{Organic and Biomolecular Chemistry}},
  title        = {{Spiro-bicyclo[2.2.2]octane derivatives as paclitaxel mimetics. Synthesis and toxicity evaluation in breast cancer cell lines.}},
  url          = {{http://dx.doi.org/10.1039/c3ob41417e}},
  doi          = {{10.1039/c3ob41417e}},
  volume       = {{11}},
  year         = {{2013}},
}